US 9068003
Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
granted A61PA61P1/00A61P1/04
Quick answer
US patent 9068003 (Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/06, A61P19/02